Literature DB >> 1567838

Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C.

A Basu1, A P Kozikowski, J S Lazo.   

Abstract

Structure-activity studies of novel synthetic analogues of lyngbyatoxin A reveal that the lactam ring but not the 7-linalyl moiety of lyngbyatoxin A is essential for the in vitro stimulation of protein kinase C (PKC). (-)-Indolactam V (ILV), which contains no hydrophobic substituent at C-7, or analogues containing either a linalyl or n-hexyl group at C-7 were equally efficacious in stimulating HeLa cell PKC in vitro and in competing with phorbol 12,13-dibutyrate for binding to PKC in intact cells. The hydrophobicity of alkyl groups at C-7, however, influenced the potency of these compounds to bind to and activate PKC. In addition, these compounds exhibited differences in their ability to translocate PKC. Lyngbyatoxin A (0.1 microM) like TPA induced a rapid translocation of PKC from the cytosol to the membrane and subsequently led to a sustained decrease in both cytosolic and membrane PKC activity. In contrast, (-)-n-hexylILV (0.1 microM) and (-)-ILV (1 microM) produced a transient and attenuated decrease in cytosolic PKC activity. At concentrations that produced half-maximal PKC stimulation, (-)-ILV did not cause any downregulation of PKC whereas lyngbyatoxin A and (-)-n-hexylILV led to 60% and 40% PKC downregulation, respectively. Western blot analyses with monoclonal antibodies to PKC isoforms indicated that reduction in PKC activity by chronic exposure to TPA or lyngbyatoxin A analogues could be explained by downregulation of PKC alpha. Constitutive expression of PKC beta and PKC gamma isoforms was low in HeLa cells and was not affected significantly by TPA or lyngbyatoxin A analogues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567838     DOI: 10.1021/bi00130a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Leveraging synthetic biology for producing bioactive polyketides and non-ribosomal peptides in bacterial heterologous hosts.

Authors:  Taylor B Cook; Brian F Pfleger
Journal:  Medchemcomm       Date:  2019-04-25       Impact factor: 3.597

2.  Expanding the Natural Products Heterologous Expression Repertoire in the Model Cyanobacterium Anabaena sp. Strain PCC 7120: Production of Pendolmycin and Teleocidin B-4.

Authors:  Patrick Videau; Kaitlyn N Wells; Arun J Singh; Jessie Eiting; Philip J Proteau; Benjamin Philmus
Journal:  ACS Synth Biol       Date:  2020-01-08       Impact factor: 5.110

3.  Novel regulation of protein kinase C-η.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

4.  High-titer heterologous production in E. coli of lyngbyatoxin, a protein kinase C activator from an uncultured marine cyanobacterium.

Authors:  Sarah E Ongley; Xiaoying Bian; Youming Zhang; Rocky Chau; William H Gerwick; Rolf Müller; Brett A Neilan
Journal:  ACS Chem Biol       Date:  2013-06-17       Impact factor: 5.100

Review 5.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

Review 6.  A review and assessment of cyanobacterial toxins as cardiovascular health hazards.

Authors:  Zorica Svirčev; Liang Chen; Kinga Sántha; Damjana Drobac Backović; Stamenko Šušak; Aleksandra Vulin; Tamara Palanački Malešević; Geoffrey A Codd; Jussi Meriluoto
Journal:  Arch Toxicol       Date:  2022-08-23       Impact factor: 6.168

7.  Rapid inhibition of myogenin-driven acetylcholine receptor subunit gene transcription.

Authors:  C F Huang; Y S Lee; M M Schmidt; J Schmidt
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.